Cancer Co. Raises $30M

Light Sciences Oncology, a Washington -based developer of a light-activated treatment for cancer tumors, has raised $30 million in a Series B round. Investors include Lehman Brothers, Deephaven Capital Management, the Malaysian Life Sciences Capital Fund, and Burrill & Co., provided the $15 million for this tranche following Fidelity Investments' $15 million in May, reports vw.